CTI BIOPHARMA CORP (CTIC) Stock Cash Flow
NASDAQ:CTIC - Nasdaq - US12648L6011 - Common Stock - Currency: USD
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.24M | -92.99M | -97.91M | -52.45M | -40.02M | |||
| Depreciation Amortization | 2.15M | 1.95M | 526.00K | 530.00K | 550.00K | |||
| Change In Working Capital | -35.94M | -7.92M | 7.86M | -2.42M | 7.76M | |||
| Interest Paid | 6.74M | 6.13M | 1.95M | 550.00K | 1.04M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 20.71M | 17.77M | 4.63M | 12.14M | 3.89M | |||
| OPERATING CASH FLOW | -82.31M | -81.19M | -84.89M | -42.21M | -27.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | 0.00 | |||
| Other Investing Activity | -58.60M | -73.85M | 12.00M | -9.60M | 28.13M | |||
| INVESTING CASH FLOW | -58.60M | -73.85M | 12.00M | -9.62M | 28.13M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 6.50M | 60.00M | -6.33M | -5.33M | -5.33M | |||
| Stock Issued/Repurchased | 9.44M | 6.37M | 56.41M | 66.41M | 0.00 | |||
| Other Financing Activity | 52.28M | 53.66M | 47.86M | 0.00 | -280.00K | |||
| FINANCING CASH FLOW | 68.22M | 120.02M | 97.94M | 61.07M | -5.61M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | 0.00 | |||
| CHANGE IN CASH | -72.69M | -35.03M | 25.05M | 9.24M | -5.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -82.31M | -81.19M | -84.89M | -42.21M | -27.82M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | 0.00 | |||
| FREE CASH FLOW | -82.31M | -81.19M | -84.89M | -42.23M | -27.82M | |||
All data in USD